Finiti
Natural health product licensed in Canada
- Licence holder
- Velovita Inc.
- NPN or DIN-HM
- 80055574
- Status
- Active licence
- Licence date
- 12 November 2014
- Revision date
- 3 December 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 6.8 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Astragalus membranaceus Source : Astragalus membranaceus - racine Extraction ratio : 100:1 Dry plant equivalent : 520 mg | 5.2 mg | Not calculated |
| N-acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 13 mg | Not calculated |
| Portulaca oleracea Source : Sommité Extraction ratio : 10:1 Dry plant equivalent : 132 mg | 13.2 mg | Not calculated |
| Punica granatum Source : Punica granatum, Fruit Extraction ratio : 30:1 Dry plant equivalent : 240 mg | 8 mg | Not calculated |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 1.7 mg | 6,800 µg |
| Vitamine B12 Source : Vitamine B12 | 60.4 mcg | 241.6 µg |
| Saccharomyces cerevisiae Source : Cellule brisée Potency : 0 Beta-1,3/1,6-Glucan 11 mg | 16 mg | Not calculated |
| Laminaria japonica Source : En entier Extraction ratio : 28:1 Dry plant equivalent : 456.4 mg | 16.3 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 13 mg | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 25 mg | 100,000 µg |
Non-medicinal ingredients
Silice, farine de riz, Concentré de tocotriénol, Curcumine, d-alpha tocophérol, Modified food starch, Hypromellose, D-Mannitol, Quercétine, Maltodextrine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant for the maintenance of good health. A factor in the maintenance of good health. Used in Herbal Medicine to help maintain a healthy immune system. Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80055574
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.